1. Home
  2. SNDR vs ICUI Comparison

SNDR vs ICUI Comparison

Compare SNDR & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Schneider National Inc.

SNDR

Schneider National Inc.

N/A

Current Price

$26.11

Market Cap

4.7B

Sector

Industrials

ML Signal

N/A

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

N/A

Current Price

$133.06

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNDR
ICUI
Founded
1935
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.9B
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
SNDR
ICUI
Price
$26.11
$133.06
Analyst Decision
Hold
Buy
Analyst Count
13
5
Target Price
$27.77
$182.25
AVG Volume (30 Days)
729.1K
263.1K
Earning Date
04-29-2026
05-22-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
100.62
EPS
0.59
0.03
Revenue
$5,674,300,000.00
$2,231,262,000.00
Revenue This Year
$5.14
N/A
Revenue Next Year
$6.49
$4.46
P/E Ratio
$43.49
$4,406.67
Revenue Growth
7.25
N/A
52 Week Low
$20.11
$107.02
52 Week High
$30.98
$160.29

Technical Indicators

Market Signals
Indicator
SNDR
ICUI
Relative Strength Index (RSI) 36.44 32.88
Support Level $24.02 $125.04
Resistance Level $27.09 $136.39
Average True Range (ATR) 1.07 6.29
MACD -0.30 -2.10
Stochastic Oscillator 26.52 17.68

Price Performance

Historical Comparison
SNDR
ICUI

About SNDR Schneider National Inc.

Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: